Pregnant women who are hemophilia B carriers have more than three times the risk of bleeding following childbirth than…
Articles by Ana Pena, PhD
Updated results from the Alta trial show that a single infusion with the highest dose of SB-525, an…
Marstacimab, an experimental treatment in clinical testing for hemophilia A and B, was able to restore clotting…
Preventive treatment with Hemlibra (emicizumab)Â is superior to replacement therapy with factor VIII infusions for reducing bleed rates…
Cell therapies may be a feasible way of achieving a long-term correction of bleeding disorders, preclinical data shared by…
The ongoing Phase 1/2 Alta trial continues to show that a single infusion of SB-525, an investigational gene…
U.S. doctors caring for people with hemophilia are more likely to make treatment…
A single infusion of AMT-061, an investigational gene therapy for hemophilia B, continues to…
Bleeding episodes, chronic pain, and the presence of inhibitors in children with hemophilia cause emotional stress for caregivers and increase their…
Maintaining high concentrations of Adynovate in the blood of hemophilia A patients decreases…